Open AccessPrevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins
Author(s) -
Georg Stüssi,
Jörg Halter,
Eveline Bucheli,
Piero V. Valli,
Lutz Seebach,
J Gmür,
Aloïs Gratwohl,
Urs Schanz,
Jakob Passweg,
Jörg D. Seebach
Publication year - 2009
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.13356
Subject(s) - pure red cell aplasia , abo blood group system , transplantation , red blood cell , medicine , immunology , aplasia , hematopoietic stem cell , stem cell , hematopoietic stem cell transplantation , aplastic anemia , haematopoiesis , blood cell , biology , bone marrow , genetics
Persistent anti-donor isoagglutinins after major ABO blood group incompatible hematopoietic stem cell transplantation may cause delayed red blood cell engraftment and post-transplant pure red cell aplasia.